Regeneron Acquires 23andMe for $256 Million
Regeneron Pharmaceuticals, a leading biotechnology company, has announced its acquisition of 23andMe for $256 million. 2...
Business
Technology
Health
23andMe Acquired for $256 Million; User Data Protection Promised
Genetic testing company 23andMe, facing financial difficulties, has agreed to be acquired for $256 million. Regeneron, a...
Business
Technology
Health
Science
Regeneron Acquires 23andMe for $256 Million
Biotech giant Regeneron is set to purchase genetic testing firm 23andMe for $256 million. The acquisition comes as 23and...
Business
Technology
Health
Previous
1
Next